T1	Participants 146 194	patients with chronic idiopathic urticaria (CIU)
T2	Participants 422 464	AH-resistant and AH responder CIU patients
T3	Participants 849 932	The control group consisted of sex- and age-matched patents with allergic rhinitis.
T4	Participants 1093 1204	Forty-six subjects were included in the CIU group, 21 were in the R-CIU group, and 44 were in the control group
